Advertisement
ERNA or NEGG or SINT
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ERNA’s FA Score shows that 0 FA rating(s) are green whileNEGG’s FA Score has 0 green FA rating(s), and SINT’s FA Score reflects 1 green FA rating(s).
- ERNA’s FA Score: 0 green, 5 red.
- NEGG’s FA Score: 0 green, 5 red.
- SINT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ERNA’s TA Score shows that 4 TA indicator(s) are bullish while NEGG’s TA Score has 4 bullish TA indicator(s), and SINT’s TA Score reflects 4 bullish TA indicator(s).
- ERNA’s TA Score: 4 bullish, 6 bearish.
- NEGG’s TA Score: 4 bullish, 4 bearish.
- SINT’s TA Score: 4 bullish, 4 bearish.
Price Growth
ERNA (@Biotechnology) experienced а -21.74% price change this week, while NEGG (@Internet Retail) price change was +1.50% , and SINT (@Medical Specialties) price fluctuated -6.89% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.
The average weekly price growth across all stocks in the @Internet Retail industry was +0.42%. For the same industry, the average monthly price growth was +8.31%, and the average quarterly price growth was +56.07%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.80%. For the same industry, the average monthly price growth was +2.00%, and the average quarterly price growth was -0.36%.
Reported Earning Dates
ERNA is expected to report earnings on May 07, 2025.
NEGG is expected to report earnings on May 28, 2025.
SINT is expected to report earnings on May 15, 2025.
Industries' Descriptions
@Biotechnology (+1.95% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Internet Retail (+0.42% weekly)The internet retail industry includes companies that sell products and services through the Internet. With more and more consumers using online retailers, the companies have seen a big increase in the use of their services. Some of the companies in the group are focused on selling business-to-business products and services. Others sell business-to-consumer products and services. Internet retailers offer a wide variety of products like books, apparel, and electronics. Some companies even specialize in only one or two categories. One potentially critical factor for players to thrive in this space is the quality and speed of product delivery. This requires an investment in efficient distribution networks. Things like logistics are important factors in the success in the extremely competitive industry. For a company to stay relevant in the industry it must have effective pricing strategies and upgraded websites. The websites must be easy to navigate and engaging for customers. In addition to the revenues generated from straight sales, internet retailers can generate revenue from subscription fees and advertising. Amazon.com, Inc., Alibaba Group, and JD.com are some of the global leaders.
@Medical Specialties (+0.80% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| ERNA | NEGG | SINT | |
| Capitalization | 13.8M | 238M | 2.53M |
| EBITDA | -33.53M | -41.06M | -8.4M |
| Gain YTD | -55.102 | 49.659 | -11.143 |
| P/E Ratio | N/A | N/A | 10.78 |
| Revenue | 535K | 1.39B | 890K |
| Total Cash | 1.92M | N/A | 6.22M |
| Total Debt | 2.88M | 97M | 1.91M |
ERNA | NEGG | SINT | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 1 | 88 | 1 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 99 | 100 | |
SMR RATING 1..100 | 100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 95 | 35 | 58 | |
P/E GROWTH RATING 1..100 | 100 | 92 | 3 | |
SEASONALITY SCORE 1..100 | 50 | 85 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ERNA's Valuation (50) in the Medical Specialties industry is in the same range as NEGG (50) and is in the same range as SINT (50). This means that ERNA's stock grew similarly to NEGG’s and similarly to SINT’s over the last 12 months.
NEGG's Profit vs Risk Rating (99) in the Medical Specialties industry is in the same range as ERNA (100) and is in the same range as SINT (100). This means that NEGG's stock grew similarly to ERNA’s and similarly to SINT’s over the last 12 months.
NEGG's SMR Rating (100) in the Medical Specialties industry is in the same range as ERNA (100) and is in the same range as SINT (100). This means that NEGG's stock grew similarly to ERNA’s and similarly to SINT’s over the last 12 months.
NEGG's Price Growth Rating (35) in the Medical Specialties industry is in the same range as SINT (58) and is somewhat better than the same rating for ERNA (95). This means that NEGG's stock grew similarly to SINT’s and somewhat faster than ERNA’s over the last 12 months.
SINT's P/E Growth Rating (3) in the Medical Specialties industry is significantly better than the same rating for NEGG (92) and is significantly better than the same rating for ERNA (100). This means that SINT's stock grew significantly faster than NEGG’s and significantly faster than ERNA’s over the last 12 months.
| ERNA | NEGG | SINT | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 84% | 2 days ago 90% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 86% | 2 days ago 88% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 90% | 2 days ago 78% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 86% | 2 days ago 79% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 84% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 84% | 2 days ago 79% |
| Advances ODDS (%) | 8 days ago 85% | 9 days ago 85% | 10 days ago 84% |
| Declines ODDS (%) | 2 days ago 90% | 13 days ago 89% | 3 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 86% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 80% | 2 days ago 84% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| POLEX | 8.71 | 0.24 | +2.83% |
| Polar Capital Emerging Market Strs Instl | |||
| SCATX | 64.00 | 1.23 | +1.96% |
| Virtus Zevenbergen Innovative Gr Stk I | |||
| WCPSX | 40.63 | 0.76 | +1.91% |
| Communication Services UltraSectorProSvc | |||
| HAGAX | 74.44 | 1.24 | +1.69% |
| Carillon Eagle Mid Cap Growth A | |||
| DSCGX | 28.60 | 0.36 | +1.27% |
| DFA US Small Cap Growth Instl | |||
ERNA and
Correlation & Price change
A.I.dvisor indicates that over the last year, ERNA has been loosely correlated with CGEN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ERNA jumps, then CGEN could also see price increases.
| Ticker / NAME | Correlation To ERNA | 1D Price Change % | ||
|---|---|---|---|---|
| ERNA | 100% | -17.50% | ||
| CGEN - ERNA | 39% Loosely correlated | +4.29% | ||
| MDGL - ERNA | 36% Loosely correlated | +0.70% | ||
| IBIO - ERNA | 32% Poorly correlated | +5.00% | ||
| SMMT - ERNA | 31% Poorly correlated | +2.60% | ||
| ATOS - ERNA | 30% Poorly correlated | +3.29% | ||
More | ||||
SINT and
Correlation & Price change
A.I.dvisor indicates that over the last year, SINT has been closely correlated with ICCM. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if SINT jumps, then ICCM could also see price increases.
| Ticker / NAME | Correlation To SINT | 1D Price Change % | ||
|---|---|---|---|---|
| SINT | 100% | +1.30% | ||
| ICCM - SINT | 66% Closely correlated | +7.59% | ||
| STSS - SINT | 60% Loosely correlated | +6.54% | ||
| CORBF - SINT | 38% Loosely correlated | +27.12% | ||
| SMLR - SINT | 31% Poorly correlated | -0.23% | ||
| NVCR - SINT | 30% Poorly correlated | +2.35% | ||
More | ||||